4 research outputs found
Inzidenz und assoziierte Mortalität invasiver Mykosen bei Patienten mit akuter lymphatischer Leukämie
Cutaneous Angiosarcoma of Head and Neck: A New Predictive Score for Locoregional Metastasis
OBJECTIVES: Cutaneous angiosarcoma of head and neck (cAS-HN) is a malignant neoplasm with deficient data on prognostic factors. The aim of this study is to present our monocenter database on cAS-HN so far and a new predictive score for locoregional metastasis (LRM). METHODS: Retrospectively, tumor characteristics and outcome of 103 consecutive patients with cAS-HN were analyzed. The main predictors of LRM (identified by univariate and multivariate statistics) were combined to a LRM risk score. The prognostic values of stratification into high-, medium-, and low-risk groups concerning disease-specific survival (DSS), distant metastasis (DM), and progression-free survival (PFS) were evaluated. RESULTS: LRM (n = 29) and control (n = 74) groups differed significantly concerning several tumor characteristics and outcome (DM, PFS, and DSS). Patients developing LRM showed 3-, 5-, and 10-year survival rates of 32%, 16%, and 11% (mean DSS time of 36.7 months [95% confidence interval (CI) 20.5-52.8]) compared to 81%, 73%, and 69% (mean DSS time of 292.4 months [95% CI 208.4-376.5]) in controls without LRM (P < .001). The main predictors were American Joint Committee on Cancer (AJCC) stage, tumor extent, and origin of the primary tumor. The LRM risk score revealed significant higher values for the LRM group [7.14 (SD 1.46) vs 4.88 (SD 1.89), P < .001]. The high-risk group showed significantly higher risk for DM and more unfavorable DSS and PFS. CONCLUSION: The LRM risk score is a simple way to estimate the risk for LRM and DM, to stage patients, and to determine treatment options
Life with too much polyprenol: polyprenol reductase deficiency
Congenital disorders of glycosylation (CDG) are caused by a dysfunction of glycosylation, an essential step in
the manufacturing process of glycoproteins. This paper focuses on a 6-year-old patient with a new type of
CDG-I caused by a defect of the steroid 5α reductase type 3 gene (SRD5A3). The clinical features were psychomotor
retardation, pathological nystagmus, slight muscular hypotonia and microcephaly. SRD5A3 was recently
identified encoding the polyprenol reductase, an enzyme catalyzing the final step of the biosynthesis
of dolichol, which is required for the assembly of the glycans needed for N-glycosylation.
Although an early homozygous stop-codon (c.57G>A [W19X]) with no functional protein was found in the
patient, about 70% of transferrin (Tf) was correctly glycosylated. Quantification of dolichol and unreduced
polyprenol in the patient's fibroblasts demonstrated a high polyprenol/dolichol ratio with normal amounts
of dolichol, indicating that high polyprenol levels might compete with dolichol for the initiation of
N-glycan assembly but without supporting normal glycosylation and that there must be an alternative
pathway for dolichol biosynthesis